Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AtaiBeckley Inc. - Common Stock (NQ:ATAI)

7.380 -0.040 (-0.54%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 21, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,307,647
Open 7.410
Bid (Size) 7.300 (10,600)
Ask (Size) 7.440 (100)
Prev. Close 7.420
Today's Range 7.380 - 7.450
52wk Range 3.265 - 7.450
Shares Outstanding 166,010,476
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
AtaiBeckley Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of AtaiBeckley Inc. - ATAI
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Why Eli Lilly Stock Climbed Today ↗
Demand for the healthcare leader's weight-loss drugs continues to rise. 
Via The Motley Fool

Performance

YTD
+90.7%
+90.7%
1 Month
+2.8%
+2.8%
3 Month
+70.8%
+70.8%
6 Month
+90.2%
+90.2%
1 Year
+68.1%
+68.1%

More News

Read More
News headline image
A CEO With a Proven Track Record of Success in Growing and Scaling Biopharmaceutical Companies Just Appointed CEO at a Clinical-Stage Biotech, Months Before Its Pivotal Phase 3 Readout
From USA News Group
Via GlobeNewswire
News headline image
Forget Weight Loss Drugs: Here's Another Reason to Buy Eli Lilly Stock ↗
Via The Motley Fool
News headline image
Eli Lilly Is Acquiring AtaiBeckley for $2.8 Billion. Cathie Wood Thinks Another Psychedelic Drug Stock Is an Even Better Bet. ↗
Via The Motley Fool
Topics ETFs Government
News headline image
Eli Lilly Just Made a $2.8 Billion Bet That Goes Beyond GLP-1 Drugs ↗
Via The Motley Fool
News headline image
Eli Lilly Is Acquiring a Psychedelic Medicine Biotech. Here's What You Need to Know. ↗
Via The Motley Fool
News headline image
Billions Flow Into Next-Generation Depression Treatments as Pharma Innovation Accelerates
Via FinancialNewsMedia
Topics Artificial Intelligence
Unusual volume stocks in Monday's session ↗
Via Chartmill
News headline image
AtaiBeckley Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of AtaiBeckley Inc. - ATAI
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Why AtaiBeckley Stock Soared Today ↗
Via The Motley Fool
News headline image
Stock Market Today, July 16: AtaiBeckley Surges on Eli Lilly Acquisition Worth Up To $3.8 Billion ↗
Via The Motley Fool
Topics Government Stocks
What's going on in today's session ↗
Via Chartmill
Curious about the most active stocks on Thursday? ↗
Via Chartmill
News headline image
Power Movers: PRSO, ATAI, IQST, TGHL Watch Now
Via AB Newswire
Topics Artificial Intelligence Economy
Thursday's session: top gainers and losers ↗
Via Chartmill
News headline image
Halper Sadeh LLC is Investigating Whether ATAI, CCRN, NUVL are Obtaining Fair Deals for their Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
There are notable gap-ups and gap-downs in today's session. ↗
Via Chartmill
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AtaiBeckley Inc. (Nasdaq – ATAI), Distribution Solutions Group, Inc. (Nasdaq – DSGR), Cross Country Healthcare, Inc. (Nasdaq – CCRN), Nuvalent, Inc. (Nasdaq – NUVL)
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
ATAI Stock Alert: Halper Sadeh LLC is Investigating Whether AtaiBeckley Inc. is Obtaining a Fair Price for its Shareholders
From Halper Sadeh LLC
Via Business Wire
Get insights into the top gainers and losers of Thursday's pre-market session. ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
Via Benzinga
News headline image
What This $496,000 Insider Sale at AtaiBeckley Means Amid Roughly 100% Stock Run ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
AtaiBeckley Doses Last Patient in VLS-01 Phase 2b TRD Study; Plans Phase 3 in Major Depressive Disorder
From AtaiBeckley Inc.
Via GlobeNewswire
News headline image
AtaiBeckley to Join the Russell Indexes, Expanding Visibility Across U.S. Equity Markets
From AtaiBeckley Inc.
Via GlobeNewswire

Frequently Asked Questions

Is AtaiBeckley Inc. - Common Stock publicly traded?
Yes, AtaiBeckley Inc. - Common Stock is publicly traded.
What exchange does AtaiBeckley Inc. - Common Stock trade on?
AtaiBeckley Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for AtaiBeckley Inc. - Common Stock?
The ticker symbol for AtaiBeckley Inc. - Common Stock is ATAI on the Nasdaq Stock Market
What is the current price of AtaiBeckley Inc. - Common Stock?
The current price of AtaiBeckley Inc. - Common Stock is 7.380
When was AtaiBeckley Inc. - Common Stock last traded?
The last trade of AtaiBeckley Inc. - Common Stock was at 08/21/26 04:00 PM ET
What is the market capitalization of AtaiBeckley Inc. - Common Stock?
The market capitalization of AtaiBeckley Inc. - Common Stock is 1.23B
How many shares of AtaiBeckley Inc. - Common Stock are outstanding?
AtaiBeckley Inc. - Common Stock has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.